As of 2025-06-20, the Intrinsic Value of Actinium Pharmaceuticals Inc (ATNM) is -7.29 USD. This ATNM valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.46 USD, the upside of Actinium Pharmaceuticals Inc is -599.55%.
Based on its market price of 1.46 USD and our intrinsic valuation, Actinium Pharmaceuticals Inc (ATNM) is overvalued by 599.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.29 - -7.29 | -7.29 | -599.55% |
| P/E | (0.12) - (0.44) | (0.15) | -110.0% |
| DDM - Stable | (13.50) - (38.88) | (26.19) | -1893.9% |
| DDM - Multi | (0.20) - (0.44) | (0.27) | -118.8% |
| Market Cap (mil) | 45.55 |
| Beta | 1.92 |
| Outstanding shares (mil) | 31.20 |
| Enterprise Value (mil) | -19.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.47% |
| Cost of Debt | 5.00% |
| WACC | 9.47% |